Figure 1

The expression level of GPR176 in GC and its diagnostic and prognostic value. (a) The expression levels of GPR176 in pan-cancer; (b) The expression levels of GPR176 in GC cells from the CCLE dataset; (c) The expression level of GPR176 in TCGA STAD database (Tumor = 373, Normal = 32); (d) The expression level of GPR176 in paired GC samples in TCGA STAD database (N = 27); (e) ROC curve of GPR176 in TCGA STAD database; (f) The expression level of GPR176 in GC tissues (GC tissues = 50, Adjacent non-tumor tissues = 50); (g) The expression level of GPR176 in paired GC tissues (N = 50); (h) ROC curve of GPR176 in GC tissues; (i) Kaplan–Meier survival curve of GPR176 in TCGA STAD database; (j) Kaplan–Meier survival curve of GPR176 in GC tissues; (k) Comparison of immunohistochemistry images of GPR176 between GC and normal gastric tissues based on the Human Protein Atlas (*P < 0.05, **P < 0.01, ***P < 0.001).